IBD affects millions of Americans. It's estimated that 130,000 adults and children in New England are living with the disease ...
Q4 2024 Earnings Call Transcript March 13, 2025 Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, ...
Alvotech (NASDAQ:ALVOW – Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 28th, there was short interest totalling 9,400 shares, a ...
FourStatesHomepage.com on MSN22h
‘My health is in jeopardy’: Insurance denies Kansas nursing student’s prescriptionA college student from Anthony is speaking out after Blue Cross and Blue Shield of Kansas denied a medicine she has been ...
Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...
Face2Face Africa on MSN19h
Woman readies to run her first half marathon after beating paralysisA 35-year-old woman named Shaunta-Maé Alexander has comeback from being struck with paralysis to preparing for her big first ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream inf ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback